Phase III Multicentre Trial of Oral Mesalazine in Patients With Mild to Moderate Ulcerative Colitis.

NCT06176560 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

376

Enrollment

INDUSTRY

Sponsor class

Conditions

Colitis, Ulcerative

Interventions

DRUG: Mesalazine

Sponsor

Faes Farma, S.A.